地中海贫血铁过载GDF-15基因多态性及血清糖蛋白糖基化修饰的研究和意义
[Abstract]:Part 1 the correlation between GDF-15 gene polymorphism and the risk of iron overload in thalassemia and the purpose of GDF-15 expression is related to the occurrence, development and treatment of iron overload in thalassemia. This part studies the GDF-15 gene rsl058587, rsl059369 and rs4808793 single nucleotide polymorphisms (SNP) loci in the iron overload of thalassemia The genetic polymorphism of rsl058587, rsl059369 and rs4808793 loci and the genetic susceptibility to iron overload in thalassemia were investigated to provide experimental basis for the pathogenesis and treatment of iron overload in thalassemia. Methods collected from the Mediterranean region of Guangxi were collected. 122 patients with iron overload, 162 cases of iron free overload, and 128 healthy subjects were selected as the control group. Polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) was used to detect the gene distribution frequency of GDF-15 gene rsl058587, rsl059369 and rs4808793 loci in the case group and the control group, and the DNA sequencing method was used to determine the corresponding base. Hardy-Weinberg equilibrium (HWE) law was used to test the distribution differences between the group representative and the comparable.SNP alleles and genotypes by the chi square test. The relationship between the SNP polymorphism and the risk of iron overload in thalassemia was analyzed by the logistic regression method. There was no statistical difference between the three groups in the sex and age composition. By HWE's law, the P values of two loci of rs1059369 and rs4808793 were both greater than 0.05, indicating that the selected samples were representative of the group, while the P value of the rs1058587 site was less than 0.001, and the genotype distribution difference between the three groups of the.Rs1059369 loci was statistically significant (P0.05) without HWE balance test (P0.05); the control group allele scores were statistically significant (P0.05). There was no significant difference in the frequency of distribution between the iron overload group and the iron overload group (P0.05). There was no statistical difference between the iron overload group and the control group and the iron overload group (P0.05). The frequency of AA and AT genotype in the iron overload patients was significantly higher than that in the normal group and the iron overload group, and the risk of iron overload in thalassemia was increased (OR=2.297,95%CI=1.158-3 .1014, P=0.002); the risk of iron overload with A genotype increased (OR=2.259,95%CI=1.177-3.031, P=0.003); further analysis of the dominant and recessive models, the A carrying frequency (AA+AT) of the allele (AA+AT) in the control group, the iron overload group and the iron overload group increased gradually (P=0.005), and increased the risk of iron overload (OR). =2.553,95%CI=1.177-3.031, P=0.003).Rs4808793 locus control group was significantly different from the iron overload group and iron overload group (P0.05), and there was no statistical difference in the genotype distribution frequency of the two experimental groups (P0.05). The frequency of allele distribution in the control group was more than that in the iron overload group and the iron overload group. P0.05, there was no significant difference in the frequency of allele distribution in the two experimental groups (P0.05); the frequency of CC and CG genotype in iron overload patients was significantly higher than that in the normal group and the iron free overload group, and the risk of iron overload in thalassemia increased (OR=1.295,95%CI= 0.557-1.631, P=0.005); the risk of iron overload carrying CC genotype was the risk of iron overload. Increase (OR=1.275,95%CI=0.658-1.589, P=0.016); to further analyze the dominant and recessive models, we can see that the allele C carrying frequency (CC+CG) in the control group, the iron overload group and the iron overload group gradually increase, there is a significant difference (P=0.013), increasing the risk of iron overload (OR=1.159,95%CI=0.797-1.359, P=0.553). Conclusion GDF-15 gene Polymorphic loci rs1058587 exists GG, CG genotype, CG type, and no CC genotypes. It is very likely that the frequency of mutant alleles in Guangxi population is very low and the sample size is small. It is not enough to detect the polymorphism of.GDF-15 gene polymorphisms of rs1059369 and rs4808793 in the mutant homozygote and thalassemia and iron overload. There is a certain correlation, but there is no significant correlation between the polymorphism of rs4808793 and the iron overload of thalassemia. The background and purpose of the study on the correlation between the second part of the GDF-15 SNP genotype and serum GDF-15, EPO, Hepc and iron metabolism is the regulatory factor in the regulation of Hepc. It is a regulatory factor in the formation of iron metabolites and red lines. The serum levels of GDF-15 in patients, especially in severe patients, are significantly higher than those in the normal population, which indicates that GDF-15 is closely related to the development of iron overload in thalassemia, but the mechanism of GDF-15 in the iron overload of thalassemia and its impact on the prognosis are still unclear. The relationship between the circulation level and its genotype and the iron overload of thalassemia It is not clear that the relationship between the severity of thalassemia and the severity of iron overload is essential to elucidate the mechanism of iron overload. Therefore, this project studies the level of GDF-15 in thalassemia and the correlation with iron metabolism. We hope to find the relationship between GDF-15 and iron overload, and increase the detection index for the diagnosis of iron overload. 284 cases of thalassemia were selected from the Department of Hematology of Guangxi Medical University from August 2016 to February 2017, including 122 cases of iron overload group, 162 cases of iron free overload group, 123 men, 161 women and 0-60 years old. The cases of thalassemia iron overloading cases were all conformed to Zhang Zhinan's diagnostic and therapeutic standards for hematological diseases and the standard of curative effect. The Chinese expert consensus of the three edition and < iron overload diagnosis and treatment >. 68 patients with dependent blood transfusion in the thalassemia iron overload group and 54 cases of non dependent blood transfusion, all cases were from Guangxi, excluding other types of anemia, infectious diseases, tumor, liver and bone disease. Control group: the same period of Guangxi Medical University. 128 cases of health checkup in a Affiliated Hospital, 54 men and 74 women, were all excluded from anemia, inflammation, tumor and other diseases. The serum ferritin, transferrin level was in normal reference range, normal subjects were examined. The serum levels of GDF-15, EPO, Hepc, FER, Tr F were tested by WB. The results were tested, the control group, thalassemia was no There were significant differences in serum Hb, GDF-15, EPO, Hepc, FER, Tr F and Hepc/FER (P0.05) in the iron overload group and the iron overload group of thalassemia. There were significant differences between the two groups of serum Hb, GDF-15, EPO, EPO. Statistical difference (P0.05). The correlation between GDF-15 level and Hb, EPO, Hepc, FER, Tr F and other indexes was analyzed. It was found that the level of GDF-15 in the serum of all the subjects was positively correlated with EPO, Hepc, FER and other levels. There was no correlation between the change of genotype and allele distribution frequency of rs1059369 and rs4808793 loci and negative correlation with the level of Hb. Conclusion the level of GDF-15 in 1. thalassemia patients increased with the decrease of Hb level, suggesting that the level of GDF-15 in thalassemia patients was associated with anemia and anoxia, and 2. thalassemia patients had a sharp GDF-15 level. No correlation between the polymorphism of GDF-15 gene polymorphic loci rs1059369 and rs4808793; 3. compared with GDF-15, Hepc, Hepc/FER is a more accurate and better diagnostic indicator of iron overload. The third part of thalassemia iron overload serum glycoprotein sugar spectrum differences and significance analysis background and purpose iron overload can cause a variety of viscera. Functional impairment involves the progression, efficacy and prognosis of thalassemia. Glycosylation is a common post-translational modification, which plays an important role in immune cell adhesion, signal transduction, structural stability, receptor composition, cell differentiation and development, and immunoregulation. The serum samples of patients with anemia of iron overload were analyzed in order to study the characteristic changes of glycoprotein sugar spectrum, screening the diagnosis of thalassemia iron overload and the characteristic glycan markers related to activity stages, and provide ideas and basis for further diagnosis and treatment. The method experiment mainly includes the following steps: (1) the collection of serum low abundance protein: equal volume The mixed 4 groups (alpha thalassemia iron overload group, alpha thalassemia free iron overload group, beta thalassemia iron overload group and beta thalassemia free iron overload group) were used to collect serum low abundance protein with high abundance protein removal column, and (2) the low abundance protein was collected by desalination, ultrafiltration, and the concentration was treated as a pending buffer. Liquid; (3) to test low abundance protein CY5 markers; (4) dot and chip hybridization of agglutinin chips; (5) chip scanning, data extraction; (6) data statistics using SPSS16.0, data consistent with normal distribution and variance of data using two independent samples of the average number of t tests, square difference using non parametric rank sum test. (7) lectin Blotting Technology to detect AAL, LC The affinity of A and WGA three lectins to serum glycoproteins was proved to be reliable. Results in this study, 4 groups of samples were screened out of 34 different agglutinin positive affinity signals, of which alpha thalassemia screened 19 differential agglutinin and beta thalassemia to screen 15 differential coagulabilities. AAL, LCA, ABL, AMA, MNA-M, DBA, GHA, GSL1, GSL1b4, HAL, GSL2, GNL, HAL, and agglutinin affinity. The affinity of HPL, DSA and MAL-II was weakened. Lectin blot technique showed that the affinity of three lectins to serum glycoproteins of AAL, LCA and WGA was consistent with the results of lectin chip. Conclusion the changes of various agglutinin affinity signals are different, indicating the blood of different types of thalassemia in the process of iron overload in thalassemia. The sugar chain structure of the glycoprotein has a complex and specific change, which suggests that the specific glycemic spectrum of different types of sera has a certain experimental basis as a biomarker for the diagnosis of thalassemia iron overload or the classification of disease.
【学位授予单位】:广西医科大学
【学位级别】:博士
【学位授予年份】:2017
【分类号】:R556.61
【相似文献】
相关期刊论文 前10条
1 杨军发;;地中海贫血一例[J];临床放射学杂志;2006年02期
2 黄心茹;;惠州市地中海贫血的现状分析及干预[J];内蒙古中医药;2008年15期
3 吕福通;谢丹尼;陈美佳;陈一君;商昌友;周艳洁;;地中海贫血干预的跟踪随访工作探讨[J];中国计划生育学杂志;2009年05期
4 ;广西壮族自治区卫生厅与国际地中海贫血协会签订合作协议[J];广西医学;2010年06期
5 黄继贤;肖捷;钱春艳;;18例成人脾不大地中海贫血临床特点分析[J];中国实用医药;2010年24期
6 ;国际地中海贫血协会在南宁举办地中海贫血防治研讨会[J];广西医学;2010年12期
7 李莉艳;李强;宋兰林;靳旺杰;余艳红;钟梅;;69例αβ复合型地中海贫血的血液学和基因型研究[J];实用妇产科杂志;2011年05期
8 张慧敏;李少英;刘维强;马晓燕;黎青;;αβ复合型地中海贫血的分子检测及血液学分析[J];中国优生与遗传杂志;2011年07期
9 蓝柳燕;王君;林漫燕;;822例地中海贫血患者基因检测结果分析[J];实验与检验医学;2011年03期
10 李亮;周万军;熊符;商璇;魏小凤;;开办“地中海贫血技术骨干培训班”的教学实践[J];继续医学教育;2011年06期
相关会议论文 前10条
1 陆华;;地中海贫血治疗新进展[A];2012年中国药学大会暨第十二届中国药师周论文集[C];2012年
2 张玲;;广东地区B-地中海贫血复合a-地中海贫血的分布调查[A];中华医学会第八次全国检验医学学术会议暨中华医学会检验分会成立30周年庆典大会资料汇编[C];2009年
3 喻芳;;预防地中海贫血[A];贵州省生殖医学与遗传学分会2010年第二届年会论文集[C];2010年
4 姜烈君;;脐血血红蛋白电泳筛查地中海贫血[A];第五次全国中青年检验医学学术会议论文汇编[C];2006年
5 王桂文;姚辉璐;陈萍;贾文广;彭立新;黎永青;;地中海贫血的单细胞拉曼光谱分析与判别[A];中国光学学会2006年学术大会论文摘要集[C];2006年
6 潘红飞;黄涛生;潘红飞;李强;冯燕妮;雷志英;韦红卫;黄月艳;黄惊鸿;林娜;徐群青;凌赛泳;陈霞静;龙桂芳;黄涛生;;广西少数民族地中海贫血研究近况[A];中华医学会第十四次全国儿科学术会议论文汇编[C];2006年
7 何梅;苏惠;黄越华;何龙;;137例地中海贫血出生相关因素分析[A];中国医院协会病案管理专业委员会第15届全国病案管理学术会议论文集[C];2006年
8 王树胜;于翠梅;;9600例地中海贫血的结果分析与研究[A];中华医学会第七次全国检验医学学术会议资料汇编[C];2008年
9 张银辉;张允奇;黄烈;曾冬梅;萧晓友;王琼;陆学东;;地中海贫血的筛查与基因确诊实验选择在人群疾病诊断中的应用价值[A];中华医学会第九次全国检验医学学术会议暨中国医院协会临床检验管理专业委员会第六届全国临床检验实验室管理学术会议论文汇编[C];2011年
10 雷永红;韦慧;陈秀奇;陈亚莲;;国内外地中海贫血现状及管理模式发展[A];全国儿科护理学术交流会议论文汇编[C];2011年
相关重要报纸文章 前10条
1 记者 陈静;全区首个地中海贫血专业学组在桂成立[N];桂林日报;2010年
2 记者 江迪;防治地中海贫血病[N];人民政协报;2010年
3 陈萍;马飚会见国际地中海贫血协会主席恩格勒索斯[N];广西日报;2010年
4 陈萍;广西与国际地中海贫血协会签订合作协议[N];广西日报;2010年
5 本报记者 罗猛;“向地中海贫血宣战”[N];广西日报;2010年
6 黄治才 吴剑鹏;我国地中海贫血移植治疗达国际领先水平[N];科技日报;2012年
7 记者 操秋阳;地中海贫血防控试点范围扩大[N];健康报;2013年
8 刘燕玲;中药治“地贫”你所不知道的故事[N];健康报;2007年
9 记者 陈莺;粤成为地中海贫血高发区[N];民营经济报;2006年
10 海霞;地中海贫血离我们并不远[N];中国中医药报;2006年
相关博士学位论文 前6条
1 李兵;广东省地中海贫血流行及防控现状评价[D];南方医科大学;2015年
2 杨冠恒;用嵌合体模型评估iPS细胞对β~(654)地中海贫血的功能性补偿作用[D];上海交通大学;2012年
3 黄春妮;地中海贫血铁过载GDF-15基因多态性及血清糖蛋白糖基化修饰的研究和意义[D];广西医科大学;2017年
4 高天;基于寡核苷酸芯片的地中海贫血特异性DNA甲基化的研究[D];第三军医大学;2009年
5 田晶;2型重组腺相关病毒载体介导β珠蛋白基因治疗地中海贫血的实验研究[D];中南大学;2010年
6 林敏;中国广东省东部地区的血红蛋白病的分子流行病学调查[D];南方医科大学;2012年
相关硕士学位论文 前10条
1 刘立芳;孕前疾病筛查地中海贫血和叶酸的数据处理与分析[D];昆明理工大学;2015年
2 王承华;44例地中海贫血住院患者的基因分型与临床表现[D];遵义医学院;2016年
3 任俊香;地中海贫血疾病筛查方案的Meta分析[D];昆明理工大学;2016年
4 江珊;听力监测对地中海贫血患者治疗早期听损伤的价值和策略研究[D];广西医科大学;2016年
5 左杨瑾;β-珠蛋白基因簇潜在功能性rSNP的系统扫描:评价一个HBG1 5'UTR变异对β-地中海贫血的遗传修饰作用[D];南方医科大学;2016年
6 喻秋霞;基于二代测序靶向捕获技术准确检测地中海贫血珠蛋白基因变异[D];南方医科大学;2016年
7 王林铄;福建地区地中海贫血基因突变谱和产前基因诊断的特点[D];福建医科大学;2015年
8 郑琳;高效液相色谱和血细胞分析技术在地中海贫血及异常血红蛋白病中的应用价值[D];福建医科大学;2016年
9 宋泽阳;基于毛细管电泳的地中海贫血分析系统研制[D];深圳大学;2017年
10 黄欣;珠蛋白基因~Gγ-158C→T纯合子突变导致nd-HPFH及其复合地中海贫血的研究[D];广西医科大学;2017年
,本文编号:2143793
本文链接:https://www.wllwen.com/shoufeilunwen/yxlbs/2143793.html